Terms: = Lung cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Treatment
63 results:
1. IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation.
Ge W; Li YA; Ruan Y; Wu N; Ma P; Xu T; Shu Y; Wang Y; Qiu W; Zhao C
Oncol Res; 2024; 32(4):625-641. PubMed ID: 38560562
[TBL] [Abstract] [Full Text] [Related]
2. Evolutionary trajectories of small cell lung cancer under therapy.
George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
[TBL] [Abstract] [Full Text] [Related]
3. ep300 promotes lung cancer cell proliferation by regulating the oncogenic transcription of Hippo-YAP signaling pathway.
Li S; Shi J; Wang L; Zhang D; Zhang H
Biochem Biophys Res Commun; 2024 Jan; 692():149330. PubMed ID: 38048728
[TBL] [Abstract] [Full Text] [Related]
4. Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Chu Q; Perrone F; Greillier L; Tu W; Piccirillo MC; Grosso F; Lo Russo G; Florescu M; Mencoboni M; Morabito A; Cecere FL; Ceresoli GL; Dawe DE; Zucali PA; Pagano M; Goffin JR; Sanchez ML; Gridelli C; Zalcman G; Quantin X; Westeel V; Gargiulo P; Delfanti S; Tu D; Lee CW; Leighl N; Sederias J; Brown-Walker P; Luo Y; Lantuejoul S; Tsao MS; Scherpereel A; Bradbury P; Laurie SA; Seymour L
Lancet; 2023 Dec; 402(10419):2295-2306. PubMed ID: 37931632
[TBL] [Abstract] [Full Text] [Related]
5. I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs.
Strachowska M; Gronkowska K; Sobczak M; Grodzicka M; Michlewska S; Kołacz K; Sarkar T; Korszun J; Ionov M; Robaszkiewicz A
Biomed Pharmacother; 2023 Dec; 168():115798. PubMed ID: 37913733
[TBL] [Abstract] [Full Text] [Related]
6. Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer.
Shin DH; Jo JY; Choi M; Kim KH; Bae YK; Kim SS
Exp Mol Med; 2023 Oct; 55(10):2220-2237. PubMed ID: 37779142
[TBL] [Abstract] [Full Text] [Related]
7. Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma.
Ramesh V; Gollavilli PN; Pinna L; Siddiqui MA; Turtos AM; Napoli F; Antonelli Y; Leal-Egaña A; Havelund JF; Jakobsen ST; Boiteux EL; Volante M; Faergeman NJ; Jensen ON; Siersbaek R; Somyajit K; Ceppi P
EMBO Mol Med; 2023 Dec; 15(12):e17836. PubMed ID: 37766669
[TBL] [Abstract] [Full Text] [Related]
8. Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell lung cancer, ETCTN 10399.
Gentzler RD; Villaruz LC; Rhee JC; Horton B; Mock J; Hanley M; Kim K; Rudek MA; Phelps MA; Carducci MA; Piekarz R; Park KS; Bullock TN; Rudin CM
Oncologist; 2023 Nov; 28(11):1007-e1107. PubMed ID: 37555284
[TBL] [Abstract] [Full Text] [Related]
9. SETD1A-mediated H3K4me3 methylation upregulates lncRNA HOXC-AS3 and the binding of HOXC-AS3 to ep300 and increases ep300 stability to suppress the ferroptosis of NSCLC cells.
Shi Z; Zhang H; Shen Y; Zhang S; Zhang X; Xu Y; Sun D
Thorac Cancer; 2023 Sep; 14(25):2579-2590. PubMed ID: 37548102
[TBL] [Abstract] [Full Text] [Related]
10. Prolonged Survival of NUT Midline Carcinoma and Current Approaches to treatment.
Kaplan HG; Subramaniam S; Vallières E; Barnett T
Oncologist; 2023 Sep; 28(9):765-770. PubMed ID: 37311046
[TBL] [Abstract] [Full Text] [Related]
11. Network pharmacology and molecular docking combined with widely targeted metabolomics to elucidate the potential compounds and targets of Euphorbia helioscopia seeds for the treatment of pulmonary fibrosis.
Liu Y; Sun W; Shen N; Hao W; Xin H; Che F; Cui Y
Comput Biol Med; 2023 Jun; 160():107007. PubMed ID: 37150086
[TBL] [Abstract] [Full Text] [Related]
12. YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6.
Chen S; Lu K; Hou Y; You Z; Shu C; Wei X; Wu T; Shi N; Zhang G; Wu J; Chen S; Zhang L; Li W; Zhang D; Ju S; Chen M; Xu B
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37094986
[TBL] [Abstract] [Full Text] [Related]
13. ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing.
Machida H; Matsuo K; Tanaka M; Kitatani K; Takase A; Yokoyama K; Kajiwara H; Yasaka M; Ikeda M; Yoshida H; Hirasawa T; Mikami M
Gynecol Oncol; 2023 Apr; 171():59-66. PubMed ID: 36804622
[TBL] [Abstract] [Full Text] [Related]
14. Radiation Therapy Expenditures Through the First 8 Performance Periods of the Oncology Care Model at a Statewide Multispecialty Health System.
De B; Andres G; Bates C; Staren E; Kutscher E; Brooks DJ; Thaker GH; Buscema J; Gin R; Thaker N
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):491-499. PubMed ID: 36427644
[TBL] [Abstract] [Full Text] [Related]
15. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
[TBL] [Abstract] [Full Text] [Related]
16. Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells.
Ansari MSZ; Stagni V; Iuzzolino A; Rotili D; Mai A; Del Bufalo D; Lavia P; Degrassi F; Trisciuoglio D
Cancer Gene Ther; 2023 Jan; 30(1):124-136. PubMed ID: 36117234
[TBL] [Abstract] [Full Text] [Related]
17. Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway.
Zhang T; Xia W; Song X; Mao Q; Huang X; Chen B; Liang Y; Wang H; Chen Y; Yu X; Zhang Z; Yang W; Xu L; Dong G; Jiang F
J Hematol Oncol; 2022 Aug; 15(1):114. PubMed ID: 35982471
[TBL] [Abstract] [Full Text] [Related]
18. Epigenetic alterations of CXCL5 in Cr(VI)-induced carcinogenesis.
Ge X; He J; Wang L; Zhao L; Wang Y; Wu G; Liu W; Shu Y; Gong W; Ma XL; Wang Y; Jiang BH; Liu LZ
Sci Total Environ; 2022 Sep; 838(Pt 1):155713. PubMed ID: 35660107
[TBL] [Abstract] [Full Text] [Related]
19. Asiatic acid re-sensitizes multidrug-resistant A549/DDP cells to cisplatin by down regulating long non-coding RNA metastasis associated lung adenocarcinoma transcript 1/β-catenin signaling.
Cheng Q; Zhang S; Zhong B; Chen Z; Peng F
Bioengineered; 2022 May; 13(5):12972-12984. PubMed ID: 35609308
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in lung cancer.
Alhebshi H; Tian K; Patnaik L; Taylor R; Bezecny P; Hall C; Muller PAJ; Safari N; Creamer DPM; Demonacos C; Mutti L; Bittar MN; Krstic-Demonacos M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947995
[TBL] [Abstract] [Full Text] [Related]
[Next]
